| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 13, 2023 | GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock | |
| Apr 13, 2023 | Kura Sushi USA Announces Closing of $68.3 Million Public Offering of Common Stock | |
| Mar 31, 2023 | Nikola Announces Pricing of $100.0 Million Common Stock Transactions | PHOENIX, March 30, 2023 /PRNewswire/ -- Nikola Corporation NKLA today announced the pricing of an SEC-registered underwritten public offering and concurrent registered direct offering at a price of $1.12 per share. Nikola will sell 29,910,7... |
| Mar 30, 2023 | Viking Therapeutics Announces Pricing of $250 Million Public Offering of Common Stock | SAN DIEGO, March 29, 2023 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") VKTX, a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced t... |
| Mar 24, 2023 | 89bio, Inc. Announces Upsized Pricing of $275 Million Public Offering of Common Stock | |
| Mar 15, 2023 | ProPhase Labs Announces New $6 Million Stock Repurchase Program | |
| Mar 14, 2023 | Aridis Pharmaceuticals Announces $2.28 Million Registered Direct Offering of Common Stock | |
| Mar 8, 2023 | Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock | /EIN News/ -- EDEN PRAIRIE, Minn., March 07, 2023 (GLOBE NEWSWIRE) -- Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save a... |
| Mar 7, 2023 | Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock | IRVINE, Calif., March 07, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. BMRA ("Biomerica"), a global provider of advanced medical products, announced today the closing of its previously announced underwritten public offering of an aggr... |
| Mar 7, 2023 | Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock | |
| Mar 7, 2023 | Biomerica Announces Closing of $8 Million Underwritten Public Offering of Common Stock | |
| Mar 7, 2023 | Southern States Bancshares, Inc. Announces Renewal of $10.0 million Stock Repurchase Program | |
| Mar 3, 2023 | Biomerica Announces Pricing of $8 Million Underwritten Public Offering of Common Stock | |
| Mar 2, 2023 | Revolution Medicines Announces Pricing of $300.0 Million Public Offering of Common Stock | |
| Feb 27, 2023 | Aprea Therapeutics Announces Closing of $5.5 Million Underwritten Public Offering of Common Stock | /EIN News/ -- DOYLESTOWN, Pa., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targ... |
| Feb 27, 2023 | Aprea Therapeutics Announces Closing of $5.5 Million Underwritten Public Offering of Common Stock | |
| Feb 24, 2023 | Aprea Therapeutics Announces Pricing of $5.5 Million Underwritten Public Offering of Common Stock | DOYLESTOWN, Pa., Feb. 22, 2023 (GLOBE NEWSWIRE) — Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a biopharmaceutical company focused on developing novel synthetic lethality-based cancer therapeutics targeting DNA damag... |
| Feb 23, 2023 | Tactile Systems Technology, Inc. Announces Pricing of $32.5 Million Public Offering of Common Stock | |
| Feb 23, 2023 | Omega Therapeutics Announces $40 Million Registered Direct Offering of Common Stock | |
| Feb 22, 2023 | Aprea Therapeutics Announces Pricing of $5.5 Million Underwritten Public Offering of Common Stock | |
| Feb 22, 2023 | Baidu stock whipsaws after Chinese search giant posts revenue beat and announces $5 billion stock buyback plan | Baidu beat Wall Street's revenue estimates for its fourth fiscal quarter.
Shares of the Chinese search giant jumped in pre-market trading but tumbled as the market opened.
Advertisement
Baidu posted upbeat fourth-quarter earnings results th... |
| Feb 21, 2023 | Verrica Announces Pricing of $32.5 Million Underwritten Offering of Common Stock and Pre-Funded Warrants | |
| Feb 15, 2023 | EMCORE Announces Pricing of $17 Million Public Offering of Common Stock | |
| Feb 15, 2023 | Galera Therapeutics Announces Pricing of Registered Direct Offering of $30 Million of Common Stock and Warrants | |
| Feb 13, 2023 | Tech stock broking app Raison reaches $30 million valuation | Estonia's Raison, a private tech stock broking app and crypto asset manager, recently increased its valuation to $30 million.
The valuation upgrade, from $11.5 million previously, was confirmed by Raison investor Server Partners after Raiso... |
| Feb 10, 2023 | Altisource Announces Pricing of $20 Million Public Offering of Common Stock | |
| Feb 10, 2023 | Altisource Announces Pricing of $20 Million Public Offering of Common Stock | /EIN News/ -- LUXEMBOURG, Feb. 10, 2023 (GLOBE NEWSWIRE) -- Altisource Portfolio Solutions S.A. (“Altisource” or the “Company”) (NASDAQ: ASPS), a leading provider and marketplace for the real estate and mortgage industries, today announced ... |
| Feb 9, 2023 | AppHarvest announces pricing of $40 million underwritten public offering of common stock | |
| Feb 8, 2023 | AppHarvest announces proposed $40 million public offering of common stock | |
| Feb 7, 2023 | Treace Medical Concepts, Inc. Announces Pricing of $100.0 Million Public Offering of Common Stock | |
| Feb 3, 2023 | Avalo Therapeutics, Inc. Announces Pricing of $15 Million Public Offering of Common Stock and Warrants | WAYNE, Pa. and ROCKVILLE, Md., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. AVTX (Avalo) announced today the pricing of an underwritten public offering of 3,770,000 shares of its common stock and warrants to purchase up to an ... |
| Feb 3, 2023 | DURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants | CUPERTINO, Calif., Feb. 3, 2023 /PRNewswire/ -- DURECT Corporation DRRX ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver disea... |
| Feb 2, 2023 | Avalo Therapeutics, Inc. Announces Pricing of $15 Million Public Offering of Common Stock and Warrants | |
| Jan 25, 2023 | Jasper Therapeutics Announces Pricing of $90 Million Public Offering of Common Stock | |
| Jan 25, 2023 | Chevron Increases Quarterly Dividend; Announces $75B Stock Repurchase Program | The Board of Directors of Chevron Corporation CVX today declared a quarterly dividend of one dollar and fifty-one cents ($1.51) per share, an increase of nine cents ($0.09) per share or approximately 6 percent. The dividend is payable March... |
| Jan 19, 2023 | Akoustis Announces Pricing of Public Offering of $30.0 Million of Common Stock | |
| Dec 21, 2022 | HBT Financial, Inc. Announces Authorization of New $15 Million Stock Repurchase Program | |
| Dec 21, 2022 | HBT Financial, Inc. Announces Authorization of New $15 Million Stock Repurchase Program | /EIN News/ -- BLOOMINGTON, Ill., Dec. 21, 2022 (GLOBE NEWSWIRE) -- HBT Financial, Inc. (NASDAQ: HBT) (the “Company” or “HBT Financial”) announced today that its Board of Directors has approved a new stock repurchase program (the “Program”) ... |
| Dec 16, 2022 | Novavax Announces Pricing of $65 Million Public Offering of Common Stock | GAITHERSBURG, Md., Dec. 16, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced the pricing of an u... |
| Dec 15, 2022 | Novavax Announces Proposed $125 Million Public Offering of Common Stock | GAITHERSBURG, Md., Dec. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced a proposed underwri... |
| Dec 8, 2022 | Prometheus Biosciences, Inc. Announces Pricing of Public Upsized $500 Million Offering of Common Stock | |
| Dec 7, 2022 | Syndax Announces Pricing of $150 Million Public Offering of Common Stock | WALTHAM, Mass., Dec. 6, 2022 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") SNDX, a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies... |
| Dec 7, 2022 | ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock | /EIN News/ -- RAMSEY, N.J. and BOCA RATON, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq:ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and de... |
| Dec 7, 2022 | ADMA Biologics Announces Pricing of Public Offering for $60 Million of Common Stock | |
| Dec 7, 2022 | CIB Marine Bancshares, Inc. Announces $4.8 Million Redemption of Preferred Stock | |
| Dec 6, 2022 | Midland States Bancorp, Inc. Announces Authorization of New $25 Million Stock Repurchase Program | |
| Dec 6, 2022 | Clearfield Announces Proposed $100 Million Public Offering of Common Stock | |
| Dec 6, 2022 | Clearfield Announces Pricing of Upsized $120 Million Public Offering of Common Stock | |
| Dec 2, 2022 | FTI Consulting, Inc. Announces $400.0 Million Stock Repurchase Authorization | WASHINGTON, Dec. 02, 2022 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. FCN today announced that on December 1, 2022, FTI Consulting's Board of Directors authorized the additional amount of $400.0 million to repurchase its outstanding shares of ... |
| Dec 2, 2022 | FTI Consulting, Inc. Announces $400.0 Million Stock Repurchase Authorization | /EIN News/ -- WASHINGTON, Dec. 02, 2022 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that on December 1, 2022, FTI Consulting’s Board of Directors authorized the additional amount of $400.0 million to repurchase its ... |
| Dec 2, 2022 | FTI Consulting, Inc. Announces $400.0 Million Stock Repurchase Authorization | |
| Dec 1, 2022 | Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock | |
| Dec 1, 2022 | Aziyo Biologics, Inc. Announces Pricing of $11.2 Million Public Offering of Common Stock | /EIN News/ -- SILVER SPRING, Md., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (“Aziyo”), a biologics company with a portfolio of regenerative products aimed at improving compatibility between medical devices and t... |
| Nov 18, 2022 | Cassava Sciences Announces $50 Million Registered Direct Offering of Common Stock | |
| Nov 14, 2022 | Bank OZK Announces $300 Million Stock Repurchase Program | |
| Nov 14, 2022 | eGain Reports Record Revenue in First Quarter of Fiscal 2023, Up 20% Year Over Year; Announces $20 Million Stock Repurchase Program | |
| Nov 4, 2022 | Rain Therapeutics Announces $50 Million Registered Offering of Common Stock | |
| Oct 31, 2022 |
Align Technology announces $200M stock repurchase agreement | Align Technology (Nasdaq:ALGN) announced today that it entered into a new, accelerated stock repurchase agreement with Goldman Sachs.
Tempe, Arizona-based Align agreed to repurchase $200 million of its common stock under its $1 billion stoc... |
| Oct 31, 2022 | Ever-Glory Seeks Shareholders' Vote For Going-Dark and Announces $3.5 Million Stock Repurchase Program | NEW YORK, Oct. 31, 2022 /PRNewswire/ -- Ever-Glory International Group, Inc. (the "Company" or "Ever-Glory") (NASDAQ: EVK), a retailer of branded fashion apparel and a leading global apparel supply chain solution provide... |
| Sep 30, 2022 | Daseke Announces $40 Million Stock Repurchase Program | ADDISON, Texas, Sept. 30, 2022 (GLOBE NEWSWIRE) -- Daseke, Inc. (NASDAQ: DSKE) (“Daseke” or the “Company”), the premier North American transportation solutions specialist dedicated to servicing challenging industrial end-markets, announced ... |
| Sep 27, 2022 | Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock | ENGLEWOOD CLIFFS, NJ , Sept. 27, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (formerly OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today ... |
| Sep 19, 2022 | Allakos Announces Pricing of $150 Million Underwritten Offering of Common Stock | SAN CARLOS, Calif., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of allergic and inflammatory diseases, today announced the pricing of an... |
| Sep 13, 2022 | Codiak Announces Pricing of $20 Million Public Offering of Common Stock and Warrants | CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. CDAK ("Codiak"), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, announ... |
| Sep 12, 2022 | Codiak Announces Pricing of $20 Million Public Offering of Common Stock and Warrants | CAMBRIDGE, Mass., Sept. 12, 2022 (GLOBE NEWSWIRE) -- Codiak BioSciences, Inc. (Nasdaq: CDAK) (“Codiak”), a clinical-stage biopharmaceutical company pioneering the development of exosome-based therapeutics as a new class of medicines, announ... |
| Sep 9, 2022 | New Tax on Stock Buybacks Would Have Raised Over $8 Billion in 2021, Study Says | |
| Sep 6, 2022 | PetIQ, Inc. Announces $30 Million Stock Repurchase Program | EAGLE, Idaho, Sept. 06, 2022 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication and wellness company, today announced that as part of the Company's long-term strategy to maximize stockholder ... |
| Sep 2, 2022 | Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Closing of $25 Million Public Offering of Common Stock | SHENZHEN, China, Sept. 2, 2022 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (NasdaqCM: ATXG), an integrated service provider focusing on garment manufacturing, logistics service, property management... |
| Aug 31, 2022 | Addentax Group Corp. Announces Uplisting to Nasdaq Capital Market and Pricing of $25 Million Public Offering of Common Stock | SHENZHEN, China, Aug. 31, 2022 /PRNewswire/ -- Addentax Group Corp. ("Addentax" or the "Company") (NasdaqCM: ATXG), an integrated service provider focusing on garment manufacturing, logistics service, property management... |
| Aug 16, 2022 | IN8bio Announces Closing of $10.25 Million Underwritten Public Offering of Common Stock | NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T cell therapies utilizing its DeltEx platform, today ann... |
| Aug 11, 2022 | IN8bio Announces Pricing of $10.25 Million Underwritten Public Offering of Common Stock | NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative gamma-delta T cell therapies utilizing its DeltEx platform, today ann... |
| Aug 11, 2022 | OrthoPediatrics Corp. Announces Pricing of $125 Million Public Offering of Common Stock and Pre-Funded Warrants | WARSAW, Ind., Aug. 11, 2022 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the pricing of its pre... |
| Aug 11, 2022 | Athenex, Inc. Announces Pricing of $30 Million Public Offering of Common Stock and Warrants | BUFFALO, N.Y., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Athenex, Inc. (“Athenex”) (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and ... |
| Jun 24, 2022 | Toshiba stock surges 6.5% on report of bids at $22-billion valuation | Toshiba shares jumped as much as 6.5 per cent on Thursday after Reuters reported bidders are considering offering up to 7,000 yen per share to take the company private, which would value the deal at about $22 billion.
Toshiba has been solic... |
| Jun 17, 2022 | Northfield Bancorp, Inc. Announces New $45.0 Million Stock Repurchase Program | WOODBRIDGE, N.J., June 17, 2022 (GLOBE NEWSWIRE) -- NORTHFIELD BANCORP, INC. (Nasdaq:NFBK) (the “Company”), the holding company for Northfield Bank, announced today that its Board of Directors has authorized a new stock repurchase program o... |
| Jun 10, 2022 | BIMI Announces Entering into a $5 million Stock Purchase Agreement | NEW YORK, June 10, 2022 (GLOBE NEWSWIRE) -- BIMI International Medical Inc. (NASDAQ: BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced that on June 9, 2022, the Company entered into a Stock Purcha... |
| May 26, 2022 | Cavco Industries Reports Fiscal 2022 Fourth Quarter and Year End Results and Announces New $100 Million Stock Repurchase Program | PHOENIX, May 26, 2022 (GLOBE NEWSWIRE) -- Cavco Industries, Inc. (Nasdaq: CVCO) today announced financial results for the fourth quarter and fiscal year ended April 2, 2022 and provided updates on other business items. The current fiscal ye... |
| May 23, 2022 | FormFactor, Inc. Announces $75 Million Stock Repurchase Authorization | LIVERMORE, Calif., May 23, 2022 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) today announced that its Board of Directors approved a $75 million stock repurchase authorization.
The company is authorized to repurchase up to $75 million... |
| Mar 11, 2022 | Applied Materials Joins Tech Peers With Plans to Buy Back $6 Billion of Stock | Shares of Applied Materials were rising Friday after the semiconductor maker announced it was buying back $6 billion in stock.
The new buyback program supplements a previous authorization, which had $3.2 billion remaining at the end of the ... |
| Dec 8, 2021 | Is Palantir Stock Good Value At $19? | BRAZIL - 2020/08/26: In this photo illustration the Palantir Technologies logo seen displayed on a ... [+] smartphone. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images |
| Aug 24, 2021 | Is Carnival Stock Good Value At $22? | CHINA - 2020/03/25: In this photo illustration the cruise line company Carnival Corporation & Plc ... [+] logo seen displayed on a smartphone with a computer model of the COVID-19 coronavirus on the background. (Photo by Budrul Chukrut/... |
| Jul 30, 2021 | Is 3M Stock Appropriately Valued At $200? | UKRAINE - 2021/05/28: In this photo illustration, 3M Company logo seen displayed on a smartphone. ... [+] (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images) SOPA Images/LightRocket via Getty Images |
| Mar 2, 2021 | Here’s Why 3M Stock Looks Undervalued At $175 | POLAND - 2021/02/07: In this photo illustration a 3M logo seen displayed on a smartphone screen with ... [+] stock market graphic on the background. (Photo Illustration by Omar Marques/SOPA Images/LightRocket via Getty Images)SOPA Images/Li... |
| Feb 17, 2021 | Is NYT Stock Still Undervalued At $49? | CHINA - 2020/08/13: In this photo illustration the American newspaper The New York Times (NYT) logo ... [+] is seen on an Android mobile device with United States of America flag in the background. (Photo Illustration by Budrul Chukrut/SOPA... |
| Jun 4, 2020 | Why Zynga’s Stock Looks Undervalued At $9 | SAN FRANCISCO, CA - DECEMBER 09: The Zynga logo is displayed on the front of the company's former ... [+] headquarters on December 9, 2011 in San Francisco, California. San Francisco based social games company Zynga is preparing for its ini... |
| May 9, 2019 | Tapestry shares surge after Coach owner announces $1bn stock buyback | |
| Apr 18, 2018 | Herbalife Announces $600 Million Stock Repurchase | |
| Aug 15, 2011 | DineEquity Announces $45 Million Stock Repurchase | |
| Stock offering nets $22.1M for drug developer Chelsea Therapeutics | The stock offering that Chelsea Therapeutics (NASDAQ:CHTP) expected to bring in $19.2 million in fresh capital has raised even more money with the sale of additional shares.
Chelsea net $22.1 million that the company will devote to commerci... |
| Employee Stock Option Fund closes fifth fund at $200m | |
| Facebook-parent Meta announces $40 billion stock buyback | Meta Platforms increased its share purchase authorization by $40 billion.
The social networking company has sought to rein in costs as revenue growth has slowed in recent quarters. |
| Covidien announces $2 billion stock repurchase program | Covidien Plc.’s (NYSE:COV) board of directors approved a $2 billion stock repurchase program today.
“The board’s approval of this share repurchase program reflects its confidence in the continued growth of Covidien’s business, our sustainab... |